UCERIS
Google image searchProduct monograph
Active ingredient
budesonide, 2 MG/ACT
DIN: 02498057
Dosage form(s): FOAM
Route(s) of administration: RECTAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 18-SEP-2023
ATC:
- A07 — ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS (ATC, ATC/DDD, )
- A07E — INTESTINAL ANTIINFLAMMATORY AGENTS (ATC, ATC/DDD)
- A07EA — Corticosteroids acting locally (ATC, ATC/DDD)
- A07EA06 — BUDESONIDE (ATC/DDD)
Reference brand drug: Jorveza, Entocort
